Allison Presnell, PharmD, BCACP, BC-ADM, CPP Clinical Pharmacist Practitioner Duke Family Medicine
Learning Objectives:
Review the role of cholesterol management in the prevention of atherosclerotic cardiovascular disease (ASCVD).
Analyze guidelines on the management of blood cholesterol, focusing on secondary prevention of ASCVD.
Evaluate new treatments for the management of blood cholesterol in patients needing additional low-density lipoproteins (LDL) lowering for secondary prevention of ASCVD.
Apply practice guidelines and recent primary literature publications to patient cases on lipid management in ASCVD.
Heart disease continues to be the leading cause of death for men and women among most race and ethnic groups in the United States. Patients with a history of atherosclerotic cardiovascular disease (ASCVD) are at the highest risk of a recurrent event and often need multiple lipid-lowering therapies to achieve cholesterol goals. In the last ten years, healthcare professionals have seen the approval of several, novel pharmacotherapy drug classes for patients with the highest risk of cardiovascular disease. This presentation aims to review the most up-to-date guidelines as well as treatment for cholesterol management, focusing on LDL lowering in patients with established ASCVD.
Members: FREE Non-Members: $25.00
Date: Sunday, October 15 Time: 6:00 pm - 7:00 pm
ACPE accredited for 1.0-hour ACPE#
Upcoming Live Webinar Events
The New Era of Treating Opioid Use Disorder on November 19, 2023 (More details will be available soon. This is an encore presentation originally presented at the 2023 Convention with speaker Olivia Caron, PharmD, BCACP, CPP).
New Drug Updates for 2023 on December 10, 2023. The speaker will be Jennifer Plair, PharmD, MSPH. More details will be available soon.
